Results 1 to 10 of about 1,181 (123)

Clinical Efficacy and Changes of Serum VEGF-A, VEGF-B, and PLGF After Conbercept Treating Neovascular Age-Related Macular Degeneration [PDF]

International Journal of Ophthalmology, 2023
AIM: To evaluate the clinical efficacy and systemic safety profile of conbercept in clinical practice on vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental growth factor (PLGF) levels after intravitreal injections for the neovascular age ...
Yan Suo
exaly   +2 more sources

Effect of Subconjunctival Injection With Conbercept as an Adjuvant to Filtration Surgery for Open Angle Glaucoma: A Prospective Randomized Interventional 6-Month Follow-Up Study [PDF]

International Journal of Ophthalmology, 2019
AIM: To compare the safety and efficacy of subconjunctival injection with conbercept and 5-fluorouracil (5-FU) for open angle glaucoma (OAG) patients after filtration surgery.
Min Ke, Vikash Vikash, Tian Zheng
exaly   +2 more sources

Efficacy and safety of ranibizumab, aflibercept, and conbercept in the treatment of diabetic macular edema: a retrospective comparative study [PDF]

Scientific Reports
To compare the efficacy and safety of three first-line anti-vascular endothelial growth factor (anti-VEGF) agents: ranibizumab, aflibercept, and conbercept in the treatment of diabetic macular edema (DME).
Bowei Liu, Qian Qiao, Yalong Dang
doaj   +2 more sources

Comparison of conbercept and ranibizumab for the treatment of idiopathic choroidal neovascularization using optical coherence tomography angiography and multifocal electroretinography [PDF]

Frontiers in Pharmacology
ObjectiveThis study aimed to compare the efficacies of conbercept and ranibizumab for the treatment of idiopathic choroidal neovascularization (ICNV) using optical coherence tomography angiography (OCTA) and multifocal electroretinography (mfERG ...
Gaixia Zhai, Lin Zhu, Yuanzhen Su, Zuofen Wang   +3 more
doaj   +2 more sources

Anti-Vascular Endothelial Growth Factor Combined with Dexamethasone Implant Therapy for Macular Edema: A Randomized Controlled Trial [PDF]

Drug Design, Development and Therapy
Yunxi Ma, Junwen Wang, Mingzhu Yuan, Zimeng Zeng, Yuhe Tan, Lu Cao, Xufang Sun Department of Ophthalmology, Hubei Key Laboratory of Otolaryngologic and Ophthalmic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and ...
Ma Y, Wang J, Yuan M, Zeng Z, Tan Y, Cao L, Sun X   +6 more
doaj   +2 more sources

Differential efficacy of Conbercept vs. Ranibizumab on retinal microstructural changes in macular edema secondary to retinal vein occlusion during the loading phase [PDF]

Frontiers in Medicine
ObjectiveTo compare the efficacy of Conbercept vs.Ranibizumab on retinal microstructural changes in patients with retinal vein occlusion-associated macular edema (RVO-ME) by evaluating multidimensional OCT biomarkers during the loading phase.MethodsThis ...
Haiyue Yu, Haiyue Yu, Zhijian Yao, Juan Teng, Qin Zhang, Tiangang Liu, Guang Zhu   +6 more
doaj   +2 more sources

Enhancement of retinal Müller glia’s phagocytic activity against hard exudates by conbercept via activation of PPARγ-CD36 axis in diabetic retinopathy [PDF]

International Journal of Ophthalmology
AIM: To investigate the effects and the underlying mechanism(s) of conbercept on the phagocytosis of hard exudates (HEs) by Müller glia in diabetic retinopathy (DR).
Ying-Ying Zhu, Shi-Yue Qin, Hai Xie, Yin-Ping Liu, Xiao-Sa Li, Chao-Yang Zhang, Yan-Chun Zhang, Jing-Fa Zhang   +7 more
doaj   +2 more sources

Efficacy of Intravitreal Conbercept in Vitrectomy for Proliferative Diabetic Retinopathy: An Integrated Meta-Analysis and Bibliometric Study [PDF]

Clinical Ophthalmology
Guangda Li,1,* Mingxuan Zhang,2,* Yifeng Ke,2 Chuanzhen Zheng,3 Liangzhang Tan,2 Yongtao Li,2 Emmanuel Eric Pazo,2 Chunli Chen,4 Xinjun Ren2 1Department of Ophthalmology, Linyi People’ s Hospital, Linyi, Shandong, People’s Republic of ...
Li G, Zhang M, Ke Y, Zheng C, Tan L, Li Y, Pazo EE, Chen C, Ren X   +8 more
doaj   +2 more sources

Evaluation of Short-Term Intraocular Pressure Changes After Intravitreal Injection of Conbercept in Patients With Diabetic Macular Edema

Frontiers in Pharmacology, 2022
Background: The study concerning the influence of Conbercept, which is an anti-Vascular endothelial growth factor (VEGF) agent, in intraocular pressure (IOP) spike is limited and warrants further investigation.
Yunkao Zeng, Xiaomin Zeng, Guanrong Zhang   +2 more
exaly   +3 more sources

Ocular pharmacokinetics of intravitreal conbercept in a rabbit model following retinal scatter laser photocoagulation [PDF]

Frontiers in Pharmacology
ObjectiveThe present study aims to evaluate the ocular pharmacokinetics of intravitreal conbercept after retinal scatter laser photocoagulation.MethodsThirty male Chinchilla rabbits (60 eyes) were used in this study.
Lanlan Chen, Lanlan Chen, Hua Liu, Hua Liu, Qingrong Zhang, Qingrong Zhang, Houbin Huang   +6 more
doaj   +2 more sources